Journal
JOURNAL OF MEDICINAL CHEMISTRY
Volume 52, Issue 22, Pages 7220-7227Publisher
AMER CHEMICAL SOC
DOI: 10.1021/jm9003957
Keywords
-
Categories
Funding
- Ministerio de Educacion y Ciencia [CTQ2008/04313, SAFF 2007-623471]
- Instituto de Salud Carlos III [RD06/0016/0016, PI 070695]
- IRSIN
Ask authors/readers for more resources
We report the first examples of a new series of antioxidant-sartan hybrids (AO-sartans), which were made by adding an antioxidant fragment to the hydroxymethyl side chain of losartan. Experiments performed in cultured cells demonstrate that these new hybrids retain the ability to block the angiotensin II effect with increased antioxidant ability. In hypertensive rats, these compounds show properties that suggest they may be more useful than losartan for controlling hypertension and preventing hypertension-induced cardiovascular damage.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available